Prevymis (letermovir) - Merck (MSD)
Impaired CMV-specific CD4+ T-cell reconstitution is associated with CMV infection after letermovir cessation. (PubMed, Exp Hematol) - Jul 19, 2025 - "Our findings establish an association between CMV prophylaxis, cs-CMVi and CMV-specific T-cell response reconstitution post-allo-HSCT." 
Journal • Bone Marrow Transplantation • Cytomegalovirus Infection • Infectious Disease • Transplantation • CD4 • CD8 • IFNG
http://www.ncbi.nlm.nih.gov/pubmed/40680812
 
Chuanhe Jiang; Gang Cai; Haiyang Lu; Jiayu Huang; Luxiang Wang; Su Li; Sujiang Zhang; Xiaohong Cai; Xiaoxia Hu; Yang Cao; Zengkai Pan; Zilu Zhang
 
Jul 19, 2025
 
Prev Next